Low skeletal muscle radiodensity is a risk factor for adjuvant chemotherapy discontinuation in colorectal cancer.

Keigo YokoiAkiko WatanabeKazuko YokotaKeita KojimaToshimichi TanakaKen KojoHirohisa MiuraTakahiro YamanashiTakeo SatoKeishi YamashitaYusuke KumamotoNaoki HikiTakeshi Naitoh

Published in: International journal of clinical oncology (2024)

The low SMR group showed higher treatment incompletion rates and received lower drug doses during adjuvant chemotherapy. Low SMR independently contributed to treatment non-completion in colorectal cancer patients.

Keyphrases

skeletal muscle
type diabetes
emergency department
adipose tissue
metabolic syndrome
adverse drug